REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis

Clinical trial NCT06788535 · COMPLETED

Trial details

NCT number: NCT06788535
Sponsor: Sharmila Dorbala
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiac Amyloidosis

Start date: 2025-01-14
Primary completion: 2026-04-08
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.